BioSante Pharmaceuticals, Inc. to Present at Stifel Nicolaus Healthcare Conference and Rodman & Renshaw Global Investment Conference

Published: Aug 30, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, BioSante’s president & CEO, will present a corporate update at the Stifel Nicolaus Healthcare Conference and Rodman & Renshaw Global Investment Conferences. The presentation will provide an overview of BioSante, including an update on the LibiGel® (testosterone gel) Phase III clinical development program and a review of published results using BioSante’s GVAX Cancer Immunotherapies in combination with ipilimumab (Ipi; Yervoy; BMS).

Back to news